KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

Awards
July 2, 2025
Tabitha Yates, Emergency Department Manager, Flaget Memorial Hospital
News
July 1, 2025
KHA Affinity Partner SUNRx will host a Regional 340B Roundtable event exclusively for 340B entities in Kentucky, Indiana, Ohio, and Michigan on July 8 at the Belterra Casino Resort.
News
June 30, 2025
KHA President and CEO Nancy Galvagni joined six of her colleagues from other state associations that are part of a 17-state group fighting to protect State Directed Payments.